Correlation Between Aerovate Therapeutics and Janux Therapeutics

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Janux Therapeutics, you can compare the effects of market volatilities on Aerovate Therapeutics and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Janux Therapeutics.

Diversification Opportunities for Aerovate Therapeutics and Janux Therapeutics

0.45

Correlation Coefficient

Aerovate Therapeutics  Janux Therapeutics

Very weak diversification

The 3 months correlation between Aerovate and Janux is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Janux Therapeutics go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Janux Therapeutics

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 20.67 times less return on investment than Janux Therapeutics. But when comparing it to its historical volatility, Aerovate Therapeutics is 5.83 times less risky than Janux Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Janux Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  4,812  in Janux Therapeutics on September 19, 2024 and sell it today you would earn a total of  1,149  from holding Janux Therapeutics or generate 23.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Janux Therapeutics

Aerovate Therapeutics

Risk-Adjusted Performance

10 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Janux Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Janux Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Janux Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aerovate Therapeutics and Janux Therapeutics

The main advantage of trading using opposite Aerovate Therapeutics and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.

The idea behind Aerovate Therapeutics and Janux Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.